Double Helix appoints Sarah Frere-Cook and Ginevra Drinka
pharmafile | June 20, 2011 | Appointment | Medical Communications, Sales and Marketing |Â Â appointment, medical communications, sales and marketingÂ
Double Helix has boosted its London-based strategic market research team with two new appointments.
Sarah Frere-Cook joins as a research executive and Ginevra Drinka has been appointed as a trainee research executive.
Sarah was formerly with Hall and Partners heath for a year and a half, during which she developed her knowledge and skills in both qualitative and quantitative healthcare market research.
She has experience across a range of therapy areas including diabetes, clinical nutrition, rheumatoid arthritis, MS, Cushing’s disease and smoking cessation.
Ginevra has four years experience in psychological academic research, having worked on studies covering functional vision loss, ADHD, psychophysiology and adolescent peer group dynamics.
Related Content

Rare diseases – spinal muscular atrophy
Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …






